These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8113792)

  • 1. Down's syndrome: up-regulation of beta-amyloid protein precursor and tau mRNAs and their defective coordination.
    Oyama F; Cairns NJ; Shimada H; Oyama R; Titani K; Ihara Y
    J Neurochem; 1994 Mar; 62(3):1062-6. PubMed ID: 8113792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel correlation between the levels of beta-amyloid protein precursor and tau transcripts in the aged human brain.
    Oyama F; Shimada H; Oyama R; Titani K; Ihara Y
    J Neurochem; 1992 Sep; 59(3):1117-25. PubMed ID: 1494902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-amyloid protein precursor and tau mRNA levels versus beta-amyloid plaque and neurofibrillary tangles in the aged human brain.
    Oyama F; Shimada H; Oyama R; Titani K; Ihara Y
    J Neurochem; 1993 May; 60(5):1658-64. PubMed ID: 8473889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of beta amyloid protein precursor (APP) and tau mRNA in the aged human brain: individual variability and correlation between APP-751 and four-repeat tau.
    Oyama F; Shimada H; Oyama R; Titani K; Ihara Y
    J Neuropathol Exp Neurol; 1991 Sep; 50(5):560-78. PubMed ID: 1910077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid.
    Portelius E; Soininen H; Andreasson U; Zetterberg H; Persson R; Karlsson G; Blennow K; Herukka SK; Mattsson N
    Neurodegener Dis; 2014; 14(2):98-106. PubMed ID: 24992945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease.
    Tcw J; Goate AM
    Cold Spring Harb Perspect Med; 2017 Jun; 7(6):. PubMed ID: 28003277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymerase chain reaction quantification of lymphoid amyloid precursor protein mRNAs in Alzheimer's disease and Down's syndrome.
    Ledoux S; Bergeron C; Nalbantoglu J; Gauthier S; Cashman NR
    Neurosci Lett; 1995 Jun; 193(2):137-9. PubMed ID: 7478160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of amyloid precursor protein mRNAs in skin fibroblasts in Down's syndrome.
    Urakami K; Kataoka J; Okada A; Isoe K; Wakutani Y; Ji Y; Adachi Y; Ohno K; Takahashi K
    Dementia; 1996; 7(2):82-5. PubMed ID: 8866680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease, and Down's syndrome.
    Beyreuther K; Pollwein P; Multhaup G; Mönning U; König G; Dyrks T; Schubert W; Masters CL
    Ann N Y Acad Sci; 1993 Sep; 695():91-102. PubMed ID: 8239320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome.
    Teller JK; Russo C; DeBusk LM; Angelini G; Zaccheo D; Dagna-Bricarelli F; Scartezzini P; Bertolini S; Mann DM; Tabaton M; Gambetti P
    Nat Med; 1996 Jan; 2(1):93-5. PubMed ID: 8564851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal and glial gene expression in neocortex of Down's syndrome and Alzheimer's disease.
    Goodison KL; Parhad IM; White CL; Sima AA; Clark AW
    J Neuropathol Exp Neurol; 1993 May; 52(3):192-8. PubMed ID: 8492138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence against the overexpression of APP in Down syndrome.
    Argellati F; Massone S; d'Abramo C; Marinari UM; Pronzato MA; Domenicotti C; Ricciarelli R
    IUBMB Life; 2006 Feb; 58(2):103-6. PubMed ID: 16608822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frame-shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid beta40.
    van Dijk R; Fischer DF; Sluijs JA; Sonnemans MA; Hobo B; Mercken L; Mann DM; Hol EM; van Leeuwen FW
    J Neurochem; 2004 Aug; 90(3):712-23. PubMed ID: 15255950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNAs expression correlates with levels of APP, DYRK1A, hyperphosphorylated Tau and BDNF in the hippocampus of a mouse model for Down syndrome during ageing.
    Chaves JCS; Machado FT; Almeida MF; Bacovsky TB; Ferrari MFR
    Neurosci Lett; 2020 Jan; 714():134541. PubMed ID: 31605772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblasts of patients affected by Down's syndrome oversecrete amyloid precursor protein and are hyporesponsive to protein kinase C stimulation.
    Govoni S; Bergamaschi S; Gasparini L; Quaglia C; Racchi M; Cattaneo E; Binetti G; Bianchetti A; Giovetti F; Battaini F; Trabuechi M
    Neurology; 1996 Oct; 47(4):1069-75. PubMed ID: 8857747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain.
    Russo C; Salis S; Dolcini V; Venezia V; Song XH; Teller JK; Schettini G
    Neurobiol Dis; 2001 Feb; 8(1):173-80. PubMed ID: 11162251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease: beta-amyloid precursor protein mRNA expression in mononuclear blood cells.
    Allen JS; Murphy GM; Eng LF; Stultz KE; Davies HD; Pickford LB; Tinklenberg JR
    Neurosci Lett; 1991 Oct; 132(1):109-12. PubMed ID: 1838578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
    Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
    Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease.
    Botella-López A; Cuchillo-Ibáñez I; Cotrufo T; Mok SS; Li QX; Barquero MS; Dierssen M; Soriano E; Sáez-Valero J
    Neurobiol Dis; 2010 Mar; 37(3):682-91. PubMed ID: 20025970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.